I just read an article about the cancer drug, Avastin. I remembered also reading late last spring that Avastin had just been preliminarily approved for use in certain types of brain cancer. According to ChemoCare.com, Avastin is also used for:
Treatment of metastatic colon or rectal cancer, used as part of a combination chemotherapy regimen.
Treatment for non-squamous, non-small cell lung cancer as part of a combination chemotherapy regimen.
As part of a combination chemotherapy regimen in patients who have not recieved chemotherapy for metastatic breast cancer.
Treatment of glioblastoma (GBM) that has worsened following prior chemotherapy.
In combination with interferon alfa for the treatment of patients with metastatic renal cell carcinoma.
Note: If Avastin has been approved for one use, physicians may elect to use avastin for other problems if they believe it may be helpful.
I did find one negative article about this versatile drug titled: Questions swirl around Avastin–June–Forbes Magazine. The opening line of the article, written by Matthew Herper and Robert Langreth, states: “Cancer researchers are beginning to ask why Roche’s very expensive and very lucrative drug Avastin is not providing bigger survival gains for cancer patients.” The writer’s criticism is that Avastan often only extends a patient’s life by a few months–and that once use of the drug is stopped, sometimes the cancer seems to return more aggressively than before.
I don’t know enough about the drug and these cancers to editorialize here. Once can only hope that, as time goes on, dosing can be improved–along with the drug. But sounds like it is a start, considering several of these cancers have proven very stubborn and difficult to treat.
Feel good and keep smiling! Pat